Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence
| Status: | Completed |
|---|---|
| Conditions: | Peripheral Vascular Disease |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 40 - 75 |
| Updated: | 5/3/2017 |
| Start Date: | February 21, 2017 |
| End Date: | April 21, 2017 |
In this study, the investigators will conduct a pragmatic, cluster-randomized, controlled
trial to evaluate an active choice intervention with and without social comparison feedback
to increase physician statin prescribing rates for eligible patients.
trial to evaluate an active choice intervention with and without social comparison feedback
to increase physician statin prescribing rates for eligible patients.
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United
States. Strong evidence indicates that statin medications can reduce the risk of CVD and for
those with CVD statins have been shown to reduce mortality. Despite this evidence, statins
are under-prescribed. In this study, the investigators will test the effectiveness of nudges
targeted to physicians using active choice and social comparisons feedback to increasing the
rate at which statin medications are prescribed to patients eligible based on national
practice guidelines.
States. Strong evidence indicates that statin medications can reduce the risk of CVD and for
those with CVD statins have been shown to reduce mortality. Despite this evidence, statins
are under-prescribed. In this study, the investigators will test the effectiveness of nudges
targeted to physicians using active choice and social comparisons feedback to increasing the
rate at which statin medications are prescribed to patients eligible based on national
practice guidelines.
Inclusion Criteria:
- Patient has a primary care physician at University of Pennsylvania Health System
- Patient meets 2013 AHA/ACC guidelines for statin therapy but no record of a statin
prescription in the electronic health record
Exclusion Criteria:
- Patient has an allergy or adverse reaction to statins documented in the electronic
health record
- Patient has glomerular filtration rate less than 30 mL/min
- Physicians (and their respective patients) will be excluded if they have less than 10
patients among their entire panel that are eligible for a statin
We found this trial at
1
site
Click here to add this to my saved trials
